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Abstract 
Diabetes is a growing problem, becoming an increasing concern within prisons. Research 
suggests that as many as 4.9% of the inmate population is diagnosed with diabetes. To 
provide constitutionally required healthcare to the inmate population, corrections officials 
must identify a validated diabetes treatment modality geared toward improving diabetes 
outcomes. The purpose of this quantitative study was to evaluate the impact of a patient 
centered medical home (PCMH) based model of healthcare within the California 
Correctional Health Care Services (CCHCS) on diabetic prisoners. Using the social 
construct theory as the framework, the research questions were focused on determining 
whether there was a relationship between Hemoglobin A1C and Cholesterol LDL values 
of diabetic patients after the implementation of the complete care model (CCM) within 
CCHCS. With a sample size of 142, an ANOVA analysis using SPSS revealed that there 
was a significant decrease in Hemoglobin A1C values after the implementation of the 
CCM. However, Cholesterol LDL values did not significantly decrease. There was also a 
statistically significant increase in referrals to specialty services. The study contributes to 
positive social change by validating the PCMH model for use in the treatment of diabetes 
within a structured setting such as a prison system. The results of the study can be used to 
expand the use of CCM toward improving the health and wellness of inmates as they are 
rehabilitated for return to the community.  
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Section 1: Foundation of the Study and Literature Review  
Problem Statement 
Coordination of care is an important component of an effective delivery model of 
treatment for patients (Droz, Senn, & Cohidon, 2019). In a correctional setting, this can 
be exceptionally difficult given the patient population and environment of care within a 
prison. Noted among some of the struggles with managing diabetes in prison are frequent 
transfers of patients to different provider panels disrupting their treatment. Additionally, 
communication among treatment providers is difficult in these types of environments 
(Booles, 2014). As a result of this struggle, a landmark U.S. Supreme Court case, Estelle 
v. Gamble (1976) set forth the expectation that medical treatment in prisons is a 
constitutionally mandated requirement under the Eighth Amendment to the Constitution 
(Sonntag, 2017). This has prompted state correctional departments to make critical 
decisions about how to provide effective and quality care for patients. The State of 
California is no exception. Beyond the ruling of Estelle v. Gamble, California has 
experienced other litigation that has necessitated a federal receivership to take over prison 
healthcare delivery from the California Department of Corrections and Rehabilitation 
(CDCR; Simon, 2013). In Plata v. Brown (2011), the state was mandated to reduce the 
overcrowded prison population to more effectively focus on the delivery of medical 
treatment to the chronically ill inmates remanded to the department.  
One effort CDCR made was to establish the California Correctional Health Care 
Services (CCHCS), overseen by the federal receiver, to organize and deliver medical 
treatment (Plata v. Schwarzenegger, 2005). In 2015, CCHCS developed the complete 
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care model (CCM), based on the patient-centered medical home (PCMH) model of 
patient delivery, and adopted its policies and procedures (Kelso, 2015). The goal is to 
develop a treatment model that puts the patient at the center of the treatment team to 
improve patient care.   
The PCMH model has been studied in various settings in the past several decades 
(Agency for Healthcare Research and Quality [AHRQ], 2013); however, effectiveness 
has not been studied in a correctional setting. It is important to a have a quality healthcare 
delivery system given the fact that prisoners have a higher rate of chronic medical 
conditions when compared to the general population (Rosen, Grodensky, & Holley, 
2016). As such, it is important for health care leaders to make a conscious effort to 
provide effective treatment to patients who can be considered high risk. Patients deemed 
to be high risk, such as diabetics with high A1C values, can be some of the most difficult 
patients for any organization to manage and treat effectively, especially adding the fact 
that the patient population is incarcerated (Reagan & Shelton, 2016). CCHCS is no 
different than any other health services organization in this regard. 
Although the merits of the PCMH model have been studied in many 
environments, there is a gap in the research on how effective this type of treatment model 
is within institutionalized settings, such as prisons that prohibit the full range of health 
care options available to patients. The restrictions placed on inmates incarcerated within a 
prison system can negatively impact their ability to fully engage in self-care necessary to 
manage chronic diseases (i.e., diabetes). Further, typical managed care models of 
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healthcare, like the PCMH model, have litigation problems despite some departments of 
correction attempting to employ it (Sonntag, 2017).   
The demographics of prisons, with an increase in the chronically ill and aging 
populations (Sonntag, 2017), suggests a need for access to quality health care treatment 
that has been shown to be effective. Therefore, this study was necessary to promote 
awareness that will create social change. Without a body of research to support its 
success in these types of settings, access to this type of treatment model for inmate-
patients across the nation is limited.  
Purpose of the Study 
The purpose of this quantitative study was to identify whether there is 
a relationship between the low-density lipoprotein cholesterol (LDL) and glycated 
hemoglobin (A1C) values of diabetic patients and implementation of a PCMH model-
based delivery system within CCHCS. I also analyzed the relationship between the CCM 
implementation and numbers of referrals to specialty services that cannot be provided for 
within the prison setting and are directly required for management of diabetes. Early 
identification for the need of specialty care can improve health outcomes for these 
patients, especially with the CCM of treatment delivery, encouraging collaboration of 
care for patients. A demonstration of these relationships will exemplify the strengths of 
the CCM in CCHCS as a treatment for conditions like diabetes within a controlled and 
institutionalized environment. 
4 
 
Research Questions and Hypotheses 
Research Question 1: Will post-CCM implementation A1C values of diabetic 
patients in 2018 be significantly lower than 2014 A1C values? 
H01: For diabetic patients, the A1C levels will not be significantly lower after the 
implementation of the patient-centered medical home model.  
H11: For diabetic patients, the A1C levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
Research Question 2: Will post-CCM implementation LDL levels of diabetic 
patients in 2018 be significantly lower than 2014 LDL levels? 
H02: For diabetic patients, the LDL levels will not be significantly lower after the 
implementation of the patient-centered medical home model. 
H12: For diabetic patients, the LDL levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
Research Question 3: Is there a decrease in the number of referrals to higher 
levels of care, defined as outpatient housing unit, correctional treatment center, or 
community placement hospitalization, for diabetic patients from 2014 to 2018, 
representing the implementation of the patient-centered medical home model within 
CCHCS? 
H03: There is no significant change in the number of referrals to a higher level of 
care for diabetic patients after the implementation of the patient-centered medical home 
model.   
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H13: There are fewer referrals to a higher level of care for diabetic patients after 
the implementation of the patient-centered medical home model.  
Theoretical Framework 
The theory of social construction is foundational to understanding the PCMH 
model of healthcare delivery. Originally conceptualized by Berger and Luckman (1967), 
the theory of social construction from a health care perspective centers on identifying 
culturally and socially meaningful ways of interacting with providers and patients. The 
premise within social construction theory, that contrasting views can be valid in differing 
circumstances, is important to consider when viewing the CCM. The experiences of each 
member of the care team, including the patient, enhance the overall quality of treatment, 
which social construct theory supports by emphasizing the value in the relationship 
between patient and practitioner. By focusing on this relationship, treatment can center on 
the needs of the individual patient. Additionally, empathy is significant in this 
relationship and is also a social construct that is collectively understood (Hirshfield & 
Underman, 2017). In an environment such as a prison that can take the human nature out 
of the patient seeking treatment, using a social construction theory can help foster a 
medical relationship between the care team and the patient. For chronic diseases like 
diabetes, it is important to take the individual experience of the patient into consideration 
to employ a treatment that will be acceptable to the patient while also being empirically 
validated. From the social construction model comes the idea that the patient’s 
experience is the most important in understanding the most effective way to treat his or 
her medical conditions. Therefore, researching how the PCMH model can impact the 
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individual health outcomes of patients indicates how treatment can find meaning in often 
inhumane settings such as prisons.   
Additionally, the chronic care model is the theoretical underpinning of the PCMH 
model and the CCM, which suggests that the most effective care for chronic illness is a 
team-based approach to treat both the patient and the population (Vallente, 2018). The 
PMH model is based on the chronic care model because it focuses on primary care clinics 
as the epicenter for treatment with the patient at the center (Rosland et al., 2018). The 
focus of this healthcare delivery model is timely access to care, continuity of care, and 
multidisciplinary teamwork (AHRQ, n.d.). The overarching goal is to create a more 
comprehensive and patient-centered delivery model. Building on the core concepts of the 
PCMH model, CCHCS has created a delivery model that allows for open lines of 
commutation between patients and healthcare staff, with the treatment team being 
centered on the patient, the patient and the care team sharing in decision-making, and 
data-informed patient registries being used to improve quality and access to care (AHRQ, 
n.d.).  
The results from this study can provide direction for which variables within the 
PCMH model should be evaluated to determine if the modified prison-based PCMH 
model is as effective in improving diabetes care measures as PCMH models found in the 
community. Because of the limitations within a prison setting in fully developing a 
comparable PCMH model to community examples, it will be important to determine if 
these care measures can still be improved (Ackroyd & Wexler, 2014). When evaluating a 
theory such as the PCMH model, it is important to use secondary data to support its 
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utilization and to identify specific health outcomes (Low et al., 2015) that are either 
improved or decreased as a result of the treatment intervention. 
Nature of Study  
The main premise of this research was centered on whether the CCM, 
implemented by the CCHCS, has had a positive effect on the health of patients deemed to 
be medically high-risk, particularly those with a diagnosis of type II diabetes. CDCR has 
developed numerous registries that track patients with various medical conditions. The 
diabetes registry, and the data contained within it, documents trends in patients who have 
this condition and allowed for data collection of historical information related to diabetes 
care before and after the implementation of the PCMH model. The statistical analysis 
used for this study was a repeated measures analysis of variance (ANOVA) on the 
variables of A1C values, LDL variables, and referrals to specialty services pre- and post-
implementation of the CCM within CCHCS.   
Secondary Data Types and Sources of Information  
The data source was archival data from the CCHCS Data Warehouse, which 
contains historical health information on a large dataset for CDCR, which currently 
houses over 120,000 inmates, all of whom received some form of healthcare through 
CCHCS. This data allowed for a review of patient health trends and deeper examination 
into specific patient classifications. Utilizing health data such as A1C values for diabetic 
patients allowed for a quantitative analysis of the benefits or contraindications of the 
PCMH model. These data were also crossed referenced with additional data trends such 
as patient referrals to higher level of care and readmissions to outside hospitals within 30 
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days. This allowed me to compare the impacts of prevention medicine and the CCM on 
health indicators with verifiable aggregated patient level health outcomes. 
CCHCS Quality Management has developed patient registries that utilize metrics 
relevant to various chronic medical conditions. The diabetes registry provides 
information necessary for the care team to make informed decisions about the 
progression of treatment for patients with diabetes. For example, this registry provided 
the most recent A1C values of patients, along with treatment compliance of the patients 
as defined by medication adherence and other variables. In addition to these registries, 
CCHCS utilizes an electronic referral for specialty service databases that tracks referrals 
to specialty treatment. Finally, data were collected on when patients are transferred to a 
higher level of care due to a medical condition. This information is aggregated and 
displayed in a healthcare dashboard that is used by institutional Quality Management 
Committees as a metric for understanding the quality of healthcare within the facility.  
Literature Search Strategy and Keywords 
I used Google Scholar, Ebscohost, course textbooks, Medline, and ProQuest to 
find scholarly articles that were related to my topic of study. I also used other resources 
such as policies and procedures that were found on the CCHCS webpage. Keyword 
searches such as the Patient-Centered Medical Home Model, prison health care, 
diabetes, A1C, LDL, and social construction theory were used. I utilized research with 
publication dates within the last 5 years unless relevant supporting articles were not 
available, like various case law references that have served as legal precedence for many 
years in prison health care law. 
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Literature Review 
Introduction 
The World Health Organization (2018) suggests that as many as 422 million 
people around the world have diabetes, which represents a significant increase from the 
108 million who were diagnosed with the disease in 1980. In 2020, the Centers for 
Disease Control and Prevention estimated that there were over 30 million Americans 
living with diabetes in 2015. This constitutes roughly 9.4% of the U.S. population. 
Further, these individuals living with diabetes have experienced health complications 
such as cardiovascular disease, lower-extremity amputation, and diabetic ketoacidosis. In 
total, the overall costs of diagnosed diabetes were estimated to be $327 billion in 2017 
alone (American Diabetes Association, 2019).  
At the end of 2016, there were an estimated 1.5 million individuals incarcerated 
within Federal and State correctional systems, representing 1 in 38 Americans (Carson, 
2018). Within this population, it is estimated that the prevalence of inmates with diabetes 
is 899 per 100,000 based on statistics from 2011-2012. This rate has doubled from 2014 
(Diabetes Behind Bars, 2018). Additionally, based on a study sample from maximum-
security prison inmates in New York state, 4.9% of the inmate population carried a 
diabetes diagnosis compared to 2.4% found in the general population (Bai, Befus, 
Mukherjee, Lowy, & Larson, 2015).  
Treatment Modalities for Diabetes 
The American Diabetes Association (2018) has outlined treatment modalities that 
have been found to be effective for diabetes. The primary treatment modality is known as 
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diabetes self-management education and support, which focuses on creating an 
environment that is patient-centered, emphasizes various modalities of educational 
settings, and uses medical technology to assist with clinical decision-making (Sepers et 
al., 2015). The goal of any treatment modality for diabetes is to improve overall health 
outcomes of the patients. Health outcomes have been defined by a multitude of diabetes-
associated professional and charitable organizations as the presence of hypoglycemia, 
hyperglycemia, time in A1C range, diabetic ketoacidosis, and patient-reported outcomes 
(Agiostratidou et al., 2017). 
Patient-Centered Medical Home Model 
First theorized in the 1970s by a pediatrician, the PCMH model of healthcare 
delivery was designed to improve health care quality by enhancing the effectiveness of 
primary care (AHRQ, n.d.). As the model gained traction in pediatrics, other primary care 
systems began to look at it as an option to improve quality for their patients. In 2006, the 
American College of Physicians created a specific policy monograph highlighting the 
advanced medical home, emphasizing a treatment modality that is patient-centered, 
physician guided, cost efficient, and longitudinal. In addition, this treatment promotes 
long-standing relationships that focus on healing and meeting the needs of the patient 
(American College of Physicians, 2006). With the enactment of the Patient Protection 
and Affordable Care Act, primary care settings were incentivized to establish and 
enhance medical homes (Kane, 2019).  
There are five primary tenets associated with the PCMH model: comprehensive 
care, patient-centered care, coordinated care, accessible services, and quality and safety. 
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In comprehensive care, patients with complex medical conditions can require intensive 
medical services and multiple providers across several different environments. This can 
lead to a fractured treatment plan. The PCMH model encourages primary care providers 
to improve their capacity to treat these complex cases in-house and create a structure that 
allows for more comprehensive care (AHRQ, 2011).  
The second tenet, patient-centered care, can help manage patient health conditions 
in four primary ways: communication, self-care, partnered decision-making, and 
improving patient safety (Peikes, Pham, O’Malley, & Maxfield, 2011). Additionally, 
creating environments where active engagement of patients and families, rather than just 
focusing on symptoms, can help patients make informed clinical decisions. Patient-
centered care can be attained through a three-step process utilizing a strengths 
assessment, a feedback session, and development of strengths to achieve goals 
(Kiwanuka, Rad, & Alemayehu, 2019).  
Further, coordinated care is for cases where the primary care team cannot provide 
services to a patient given the need for specialty care. In these cases, efforts should be 
made to create medical neighborhoods to coordinate care within a structured network. 
Having a network of specialists that branch out from the primary care setting allows care 
teams to maintain a flow of information while maintaining accountability for the 
coordinated care of patients (Taylor, Lake, Nysenbaum, Peterson, & Meyers, 2011). For 
instance, Sepers et al. (2015) measured the effects of coordinated care in several PCMH 
models for patients with diabetes and found positive clinical outcomes, particularly with 
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the reduction of A1C levels, along with patient and staff satisfaction being rated 
positively. 
Accessible care is also an important aspect of a healthcare delivery model. The 
PCMH model focuses on accessibility as one of the primary components of treatment. If 
patients cannot access treatment, they will not engage in treatment and ultimately health 
outcomes decline. Reduced access to comprehensive and continuous services such as 
those found in a PCMH model may exacerbate chronic conditions. This lack of access 
can increase emergency department visits and preventable hospitalizations (Almalki, 
Karami, & Almsoudi, 2018). For example, Cai et al. (2018) surveyed rural residents to 
determine the best design for a PCMH model in an outlying area in the Midwest United 
States and found that rural residents preferred an environment that focused on privacy, 
provided seating or family in the exam room, and provided a space that supports 
information sharing. Because patients like these must travel longer distances to access 
health care services, creating an accessible environment is important to ensure they return 
and engage in their treatment.  
Quality and safety are also ensured by a PCMH model through utilizing various 
decision-support tools, evidence-based care, shared decision-making, and other strategies. 
By using these types of improvement activities, the PCMH model contributes to a 
systems-level focus on quality (AHRQ, n.d.). Quality improvement is at the heart of a 
PCMH model, which primary care settings can accomplish by continuously assessing the 
processes and identifying problems to improve the overall system (Akinci & Patel, 2014). 
For example, in a recent study of more than 23,000 primary care practices utilizing the 
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PCMH delivery model, various aspects of quality improvement were focused on using 
patient data for care delivery decisions and other practice enhancement efforts (Pereira, 
Gabriel, & Unruh, 2019). 
Finally, a critical component of any health care delivery model is the way in 
which it is perceived by the patients. The PCMH model has demonstrated positive 
responses from patients. Platonova, Saunders, Warren-Findlow, and Hutchison (2016) 
found that patients who received treatment at free clinics utilizing the PCMH model had 
highly positive impressions of the treatment and would recommend the clinics to others. 
Furthermore, low-income Spanish-speaking patients have shown positive responses to the 
PCMH model, which can be attributed to provider communication and interaction, which 
are hallmarks of the PCMH model’s concepts (Platonova et al., 2016). Additionally, the 
patient experience with a health care system is not exclusive to the medical providers. 
Ancillary staff, such as receptionists and support staff, contribute to the overall success of 
the PCMH model. By including these staff in training related to the concepts of quality 
care, patient satisfaction will improve. In addition, encouraging patient-centered 
engagement from the support staff improves patient perceptions of the entire care team 
(Solimeo, Stewart, & Rosenthal, 2016). 
Patient-Centered Medical Home Model and Diabetes 
The PCMH model has had a demonstrated positive impact on diabetes (Solberg, 
Carlin, Peterson, & Eder, 2020; Woodard et al., 2018). Clinical outcomes of the PCMH 
model have shown reduced A1C, cholesterol levels (LDL and HDL levels), and body 
mass index (Ackroyd & Wexler, 2014; Baker & Laughlin, 2017; Johnson et al., 2010; 
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Solberg et al., 2020). Further, for patients who are medically vulnerable such as those 
with low incomes, minority patients, and those who have comorbid medical conditions or 
reduced access to care, the PCMH model has resulted in greater odds of having well-
controlled A1C levels (Kinsell, Hall, Harman, Tewary, & Brickman, 2017). The PCMH 
model can also integrate self-management education as one of the primary treatments for 
diabetes control to provide patient-centered, empirically validated treatment for patients 
with diabetes. Integrating a coordinated care model that combines diabetes self-
management education and support with a PCMH model can have positive effects on 
A1C values and significant improvement of body mass index scores for patients (Sepers 
et al., 2015).  
As a part of improving patient outcomes, some of the five tenets of the PMCH 
model have been shown to be associated with treatment activation among patients with a 
diabetes diagnosis. In particular, the quality of provider interactions, as defined as 
knowledgeable and engaging interactions with patients, is rated as one of the most 
important attributes of the PCMH model that leads to higher treatment activation. There 
are also organizational aspects of the PCMH model that lead to patient activation such as 
the ability to easily and quickly schedule appointments or seek consultation from a 
member of the care team (Bilello et al., 2018). 
The body of literature surrounding the PCMH model and its impacts on diabetes 
in primary care settings is broad, however, there needs to be more focus on its application 
in other healthcare settings. Given the expanding industry of healthcare technology, there 
is a need for research on other methods of treatment delivery such as telehealth. In 
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addition, with the growing prison population, particularly with inmates who suffer from 
chronic medical conditions such as diabetes, it is imperative that additional research be 
conducted on how diabetes is managed in these types of settings. Although California is 
one of the only states where prison systems have utilized a model based on the PCMH 
model, if positive outcomes can be demonstrated in this setting, additional states might be 
willing to adopt the PCMH model to manage chronic care for inmates.  
History of Healthcare in Prison 
American prisons have been responsible for the health needs of prisoners since 
the 18th century (Sonntag, 2017). However, it was not until recently that the quality of 
treatment provided became more of a focus in the judicial system. The current healthcare 
systems present in many correctional departments across the United States have been 
implemented as the direct result of legal challenges over the course of several decades, 
where cases have suggested that prison systems violated the eighth amendment to the 
Constitution by not providing adequate healthcare for inmates (Sonntag, 2017). The first 
landmark case challenging the inadequate healthcare in prison was Estelle v. Gamble 
(1976), which suggested that the lack of provisions for healthcare services to inmates in 
the Texas Department of Corrections amounted to a deliberate indifference. In the years 
following the Estelle decision, other decisions have been made that continued to help 
form the foundation of the current healthcare systems found in state correctional systems.   
More recently, the CDCR has faced legal challenges regarding its provisioning of 
healthcare services to its inmates. Plata v. Brown (2011) is a lawsuit that reached the U.S. 
Supreme Court that argued that the extreme overcrowding of the California prisons 
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caused an inability to provide constitutionally adequate healthcare. The case revealed a 
system of denial that inmates in California prisons were not at all deserving of adequate 
medical treatment (Simon, 2013). Furthermore, as Simon (2013) suggested, “prisons that 
do not sicken or kill their prisoners must . . . necessarily be, whether designed or not, an 
Hospital…” (p. 253). The settlement agreement associated with the Plata v. Brown case 
involved the assignment of a federal receiver to oversee the totality of the health care 
delivery services within the CDCR. This oversight provided for significant enhancements 
to the delivery model and has aided in moving California closer to the provisions of 
constitutionally adequate healthcare. In the years following the receivership, the focus of 
the CCHCS Department turned to access and quality of care for the inmate-patients. As 
the system matured, a standard delivery model was adopted to improve the overall 
healthcare of the patients. In particular, CCHCS moved to formally create a modified 
version of the PCMH model known as the CCM. 
The Complete Care Model in California’s Department of Corrections and 
Rehabilitation 
The CCM was implemented within CDCR in 2014, allowing the ability to 
approach health care services with a team approach, which added an additional layer of 
patient oversight. The CCM requires CCHCS to establish care teams assigned to oversee 
coordinated patient panels and allows for a platform for program improvement (CDCR, 
2015). The CCM is a tool that allows the teams to communicate patient needs more 
comprehensively. Additionally, the CCM is a coordinated method to approach patient 
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care while addressing access to care, health maintenance, and quality improvement 
through data to better meet regulatory compliance measures (CDCR, 2015).  
The concepts of daily use of the CCM require that a set of core team members 
meet daily to discuss the patients of the day, or the patients that are to be seen that day. In 
addition, the core team members also discuss a panel of high-risk patients that are 
assigned to that care team that is tracked and displayed within the CCHCS dashboard. 
From the patients who are indicated on the dashboard, these patients may be scheduled 
that day or discussed for future follow as needed (CDCR, 2015). Additionally, the use of 
population management meetings provides opportunities for the care team to review the 
CCHCS dashboard in detail ensuring that the data is reviewed in-depth and that specific 
patients that require interdisciplinary review are spotlighted (CDCR, 2015). 
Use of healthcare informatics has allowed the CCM to produce action-oriented 
improvements to the care delivered to patients remanded to the CDCR. An array of 
resources has been created to assist with this function—most prominently the CCHCS 
Health Services Dashboard. With the dashboard, care teams and healthcare leaders at 
each prison within CDCR can assess the overall health of its system. The dashboard 
provides consolidated access to metrics developed in consultation with the Healthcare 
Effectiveness Data and Information Set. The information is typical of what health care 
organizations would monitor in the community: patient outcomes, access to care, and 
utilization and cost. The care teams can review these results on a monthly basis and 
determine areas for improved delivery of care.   
18 
 
Resources for population management activities within the care teams have also 
been developed. For example, there are a number of patient registries for high-risk 
medical conditions that allow a care team to look at the patients on their panel who have 
these conditions as well as relevant medical interventions that should occur to monitor 
the treatment progression. Each care team is expected to participate in a bi-monthly 
population management working session. In these sessions, a forum is established where 
care teams can review new clinical and organizational guidelines, identify barriers to care 
and any new resource needs, receive feedback on the performance of the clinic work, and 
manage subpopulations within the patient panel for improving overall patient outcomes 
(CDCR, 2015). 
One of the hallmarks of the CCM is a morning huddle that occurs for each care 
team to discuss patient issues that occurred yesterday, today, and tomorrow. A report is 
generated that utilizes data from numerous sources to pre-populate patient information 
for various queries to be discussed during these huddles. Examples are patients who have 
returned from a higher level of care, new patients on the panel that have recently arrived, 
medication concerns (i.e., expiring or expired prescriptions), and the day’s schedule for 
each of the members of the care team.   
Coordination of care occurs in each care team through the establishment of a care 
coordinator. Typically, the care coordinator is a licensed vocational nurse or psychiatric 
technician assigned to the care team who works collaboratively with specialty care and 
other ancillary health care services in the facility and in other environments to ensure that 
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patients who require additional care, care that the care team is not equipped to provide, 
are treated effectively and efficiently (CDCR, 2015). 
Definitions 
Care coordination: The deliberate organization of patient care activities between 
two or more participants involved in a patient’s care to facilitate the appropriate delivery 
of health care services and minimize the danger of care fragmentation. 
Care coordinator: A primary care licensed vocational nurse or psychiatric 
technician who is assigned a group of patients within the patient panel. Normally the 
patients will be less complex patients in the primary prevention group. The care 
coordinator uses his/her skills, according to his/her scope of practice, to meet the goals of 
each patient’s care plan. The care coordinator collects data, provides patient education, 
documents findings and interactions, communicates patient information, and provides 
input to the registered nurse care manager and other members of the care team. 
Care management: A collaborative process of patient assessment, evaluation, 
advocacy, care planning, facilitation, and coordination. The extent of care management 
services varies according to the complexity of the patient. 
Care team: An interdisciplinary group of health care professionals who combine 
their expertise and resources to provide care for a panel of patients. 
Complete care model (CCM): The CCM is based on the PCMH model and 
services as a foundation to which health care needs of patients are met in a timely 
manner. This model is used to reduce hospitalizations, ensure better patient outcomes, 
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and includes elements such as coordination of care, access to care, preventive care, 
comprehensive care, and continuous care for patients.   
Patient centered medical home (PCMH) model: The PCMH model seeks to 
coordinate care through a primary provider to help the patient receive the care they need 
when they need it. This model helps the patient to better understand the care they are 
receiving in a more efficient way. 
Patient panel: A clearly defined group of patients that are assigned to a particular 
care team. Every care team has one panel of patients, and every patient is assigned to a 
care team.   
Population management: Systematic assessment, monitoring, and management of 
the health care needs of identified groups of patients. 
Primary care team: An interdisciplinary team that organizes and coordinates 
services, resources, and programs to ensure consistent delivery of appropriate, timely, 
and patient-centered, evidence-based care to a designated patient panel. 
Assumptions 
One assumption was that the data provided by CCHCS encompassed all patients 
who were diagnosed with diabetes prior to the implementation of the CCM in 2014 and 
diagnosed with diabetes in 2018. By looking at only patients who carry a diagnosis of 
diabetes, the dataset was not confounded with patients without the diagnosis who did not 
refuse treatment or who required higher levels of care. If these non-diabetic patients were 
to be included, their patient outcomes could alter the results of the statistical analyses and 
create Type I or II errors.  
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The second assumption was that the patients had been treated according to 
CCHCS policies and procedures by the assigned care teams. All healthcare staff had been 
trained, coached, and mentored by regional oversight teams to conduct treatment in 
accordance with these policies and procedures. Additionally, the CCHCS Quality 
Management Unit had supplied all staff with standardized resources. As such, the 
assumption that the clinical staff were employing the CCM treatment modality was 
important to ensure that treatment was being delivered consistently to all patients. This 
reduced the likelihood that patients received treatment other than in the manner set forth 
in the CCM, which otherwise could lead to concerns about whether the CCM had any 
effect on the patient outcomes. These assumptions are important, as they reduced 
confounding variables that could have skewed the results of the statistical analyses that 
were performed in this study.  
Delimitations 
The data utilized for this study came directly from the CCHCS data warehouse 
that was maintained using strict privacy protections. No other data was used for this 
study. The participants were incarcerated individual that have diabetes and who have 
been under the jurisdiction of CDCR since at least 2014, which was the start of the CCM 
implementation. In order to establish whether the changes in patient-level outcomes were 
attributed to the implementation of the CCM, it was important to consider the outcomes 
of the patients prior to and after the implementation. In alignment with social construct 
theory, understanding how the patient and the clinical team worked together to improve 
the health and life of the patient was critical to understand the best method for achieving 
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this. In this study, the hope was to determine if the CCM was the best treatment modality 
to enhance communication and improve patient health outcomes within a correctional 
setting.  
Limitations 
The PCMH model has been shown to be successful within many community 
healthcare settings in reducing avoidable hospitalizations and supporting 
multidisciplinary team approaches (Plewnia, Bengel, & Körner, 2016). It does, however, 
have its limitations when it comes to patients with complex health care issues that require 
a specialized approach. Additionally, it has been suggested that rates of hospital 
readmissions can be reduced if the care team has communication within the first three 
days of the patient’s arrival (Low et al., 2015). A common reason for the lack of success 
is directly related to team participation, timeliness of interactions, and this three-day 
“rule.” These reasons suggest the need for the care team to not only have 
multidisciplinary interactions but that these interactions must be timely, which can be 
difficult in a prison environment. This challenge must be addressed through the CCM 
within CCHCS.  
The PCMH model has allowed various disciplines such as nursing, dental, 
administrative staff, and behavioral health services to work together to complete a 
common mission. Additionally, this allows for the disciplines to work cohesively while 
learning from each other (Costlow, Landsittel, James, Kahn, & Morton, 2015). However, 
if the disciplines are not properly coordinated, health efforts can be overlooked. There is 
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a lack of data on the patient-centered model in the prison system which requires 
additional research to further explore this topic. 
Barriers included an understanding that there are several factors that are indicative 
of successful patient outcomes for diabetes: diabetes self-management education, team-
based care, care coordination, case management, and specialty care team members. 
Ackroyd and Wexler (2014) identified several positive impacts of the PCMH model on 
outcomes for diabetic patients, such as compliance with specialty appointments and 
improvement of critical lab values associated with diabetes. It was determined that 
several factors played a crucial role in the reduction of A1C levels: team changes, case 
management, promotion of self-management, clinician education, patient education, 
facilitated relay of information, electronic patient registries, and patient reminders. 
Additional barriers included an understanding that these results suggest that the various 
components of the PCMH model can improve diabetes care measures, and as such, from 
a patient-care perspective, it is an effective model of treatment for managing diabetes. 
There were other barriers that were encountered in the logistical development of 
this study. The CDCR has an Office of Research that oversees and approves all uses of 
data pertaining to the inmates incarcerated within its institutions. The Office of Research 
requires that only aggregated information that is population-based, rather than individual 
patient-level data, be utilized in order to protect the identity of patients.   
Significance    
The results of this study could have a significant impact on the treatment provided 
to diabetic patients within correctional settings across the country. The body of literature 
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on the efficacy of the PCMH model’s ability to improve health outcomes for diabetic 
patients is broad and is often in a community outpatient setting (Dobbins et al., 2018; 
Plewnia et al., 2016). The PCMH model has shown to not only improve health outcomes, 
but patient satisfaction related to communication with providers (Janiszewski, O’Brian, & 
Lipman, 2015). In addition, research on the PCMH model has shown fiscal and 
operational improvements (Rosland et al., 2018). However, there remains a dearth of 
research surrounding the use of the PCMH model within correctional settings and it is 
essential to provide a roadmap to success for chronically ill individuals within prison 
systems.  
The focus of the CCM in relation to this study will allow for a better 
understanding of how high-risk patient populations can benefit from a team-based 
approach of health care services, particularly within the context of an incarcerated setting. 
The PCMH model has been implemented for several decades in other patient contexts but 
it has not been undertaken in a correctional setting (Berryman, Palmer, Kohl, & Parham, 
2013). The CDCR is the first correctional setting to utilize the PCMH model to create a 
healthcare delivery system which can provide access to outcome measures related to 
various chronic health conditions. As such, there is little research to suggest it can be 
implemented successfully within this context. Being able to utilize data within the CDCR 
to support its use can be beneficial not only for the patients treated within the CDCR, but 
also for other state and federal correctional systems to use this information to support the 
implementation of this model in their systems.   
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If a model like the CCM can demonstrate improved health outcomes for 
chronically ill inmate-patients, it could be used nationwide to support inmates and their 
treatment. In an effort to establish the beginnings of a body of research to support this 
model, this study will attempt to demonstrate how a systemic adoption of a modified 
PCMH model within a prison setting can improve patient outcomes for individuals with 
diabetes. These outcomes will be assessed through A1C values, LDL levels, and referrals 
to higher levels of care for these patients. This approach also required a discussion and 
review of the definition of a high-risk patient and how this definition is quantified across 
the spectrum of patients treated within CDCR. Finally, attention was placed on those 
patients who were high-risk and were diagnosed with diabetes, along with whether or not 
the CCM had a positive impact on their health outcomes.  
Researching how the PCMH model can open communication is crucial as it lends 
itself to better patient outcomes. Better patient outcomes will lead to improved treatment 
outcomes (Plewnia et al., 2016). At its core, the PCMH model seeks to put the patient at 
the center of the healthcare delivery process. The medical team is located where the 
patient is to ensure that treatment delivery is easily accessible to the patient. Ultimately, 
this model seeks to reduce access barriers, which is particularly crucial for patients with 
limited mobility or access to transportation. Overcoming these barriers by effective 
scheduling and outreach efforts will help reduce the incidences of more expensive and 
severe conditions in patients because of the increased attention to preventative care that is 
more easily achieved through effective scheduling and proximity to patients (Grant & 
Greene, 2012). This, in turn, saves resources that allows the system to address other 
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issues such as high-risk patients with chronic medical conditions, thus saving the tax 
payer’s money. Patient-centeredness has been found to better support patients in their 
overall care (Droz et al., 2019). When a patient is actively involved in the decision-
making process for their own health care needs, there is more adherence to the treatment 
plan (Droz et al., 2019). Additionally, when the patient feels involved and heard by his or 
her healthcare provider, there is more satisfaction with the overall health care provided 
(Platonova et al., 2016).  
From a global perspective, developing a more empirically validated treatment 
model for healthcare delivery of patients could help the overall population. Given the fact 
that most of the prisoners incarcerated in the CDCR will be released at some point in the 
future, having a robust treatment model for chronic medical conditions in prison means 
upon release, they are less likely to be as sick. It also demonstrates a fundamental shift in 
the underlying theory and purpose of rehabilitation associated with prison. Historically, 
prisons have served to house criminals and little else (Sonntag, 2017). Rehabilitation was 
considered a luxury. As such, many inmates were not treated as humans, but rather as 
criminals. With a change in this perspective, the quality of healthcare could improve. 
Additionally, healthier inmates would be able to take a more active role in programs 
within prison that are geared toward rehabilitation as they prepare for re-entry into 
society. If inmates are not physically well and are not treated for medical conditions, 
upon release, they are left uneducated regarding their medical conditions, and are more 
likely to become the burden of community health facilities, if they are even able to 
receive treatment at all.  Using the PCMH model to educate patients on their health 
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condition and the best way to maintain a high quality of life, they could be released to 
society healthier than when they arrived. In addition, they could enter society with a 
renewed sense of purpose and self-determination to make other positive changes in their 
lives.  
Summary and Conclusion 
The use of the PCMH model within a correctional setting could potentially offer a 
treatment modality that is collaborative, comprehensive, and evidence-based for 
managing the needs of diabetic patients. The PCMH model has already been a widely 
accepted treatment modality in numerous settings within community health care (AHRQ, 
2013).  It has also shown success in improving health outcomes for patients with diabetes 
(Baker & Laughlin, 2017; Ackroyd & Wexler, 2014).  Given the long history of 
correctional health care litigation, most notably beginning with the landmark Estelle v. 
Gamble (1976) case, it is prudent for correctional systems to identify treatment methods 
that can meet not only the legal standards of constitutionally adequate treatment, but also 
the ethical requirements of health care providers to use empirically validated treatment. 
The CDCR, in collaboration with the CCHCS, has made great strides under Federal 
Receivership to develop the CCM for health care delivery to the 120,000 inmates housed 
in California’s prisons. 
Currently, there is a gap in the literature surrounding the PCMH model and its 
efficacy within an institutional setting, such as a prison. The CDCR has attempted to 
modify the PCMH model for use with patients who are diagnosed with chronic medical 
conditions, such as diabetes. This study sought to shrink the literature gap by analyzing 
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whether or not the CDCR CCM has any effect on the health outcomes for patients 
diagnosed with diabetes and who are remanded to the custody of the CDCR. 
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Section 2: Research Design and Data Collection 
Introduction 
Research establishing the benefits of using a PCMH model or a modification of 
the model, such as the CCM, on delivery of treatment within a correctional setting has 
not been completed. Although the PCMH model is empirically validated as an 
appropriate treatment for chronic health conditions, using it within this setting has not 
been fully supported with research. Given the propensity for litigation within the 
correctional health care systems (Sonntag, 2017), it is important to establish a treatment 
modality that has research support to provide what has been determined to be 
constitutionally adequate healthcare for patients remanded to a correctional facility. 
Therefore, this study was conducted to identify how the implementation of the CCM 
within CCHCS impacted the treatment of patients with a diagnosis of diabetes. To 
accomplish this, I analyzed the relationship among patient outcomes, defined as A1C 
values, LDL values, and referrals to a higher level of care (defined within CCHCS as 
outpatient housing unit, correctional treatment center, or an outside community hospital, 
and the implementation of the CCM. 
Research Design and Rationale 
This study involved a quantitative approach to further understand the impact of 
the CCM on patients with chronic medical conditions such as diabetes. This is 
particularly important within an institutional setting, where lifestyle changes consistent 
with diabetes treatment are restricted. Patient-level outcomes were of primary focus for 
this research study with an analysis of the rate of transfers to higher levels of care 
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(hospitalizations), A1C values, and LDL values. The independent variable of this study 
was the CCM, and the dependent variables were the patients’ A1C values, transfers to 
higher levels of care (hospitalizations), and LDL values. Three research questions were 
designed to examine the relationships among these variables: 
Research Question 1: Will post-CCM implementation A1C values of diabetic 
patients in 2018 be significantly lower than 2014 A1C values? 
H01: For diabetic patients, the A1C levels will not be significantly lower after the 
implementation of the patient-centered medical home model.  
H11: For diabetic patients, the A1C levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
Research Question 2: Will post-CCM implementation LDL levels of diabetic 
patients in 2018 be significantly lower than 2014 LDL levels? 
H02: For diabetic patients, the LDL levels will not be significantly lower after the 
implementation of the patient-centered medical home model. 
H12: For diabetic patients, the LDL levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
Research Question 3: Is there a decrease in the number of referrals to higher 
levels of care, defined as outpatient housing unit, correctional treatment center, or 
community placement hospitalization, for diabetic patients from 2014 to 2018, 
representing the implementation of the patient-centered medical home model within 
CCHCS? 
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H03: There is no significant change in the number of referrals to a higher level of 
care for diabetic patients after the implementation of the patient-centered medical home 
model.   
H13: There are fewer referrals to a higher level of care for diabetic patients after 
the implementation of the patient-centered medical home model.  
To understand the impact of the CCM on the various patient outcomes, it was 
important to utilize historical data for patients who received treatment prior to the CCM 
implementation as well as data after the implementation. This type of pre- and post- test 
analysis has been used in previous studies assessing the effects of various treatment 
modalities on patient health outcomes (Johnson et al., 2010; Kinsell et al., 2017). This 
study had no constraints regarding data collection.  
Methodology 
Population 
The target population for this study was male patients who were assigned to the 
California Medical Facility and who had been housed there consistently since 2014 to 
ensure they received treatment both before and after the implementation of the CCM. The 
total population at California Medical Facility was 2,539 as of June 30, 2019 (CDCR, 
2019). This correctional institution was chosen given the higher concentration of patients 
who have long-standing medical conditions, combined with long enough sentences to 
ensure they received treatment both before and after the implementation of the CCM.  
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Sampling 
A total of 99 participants were proposed through a power analysis, with power set 
at .80, α = .05, and expecting small to moderate effect sizes (Cohen, 1992). The first 
criterion of the sample was that the patients had to have consistently been housed at CMF 
between 2014 and 2018, which reflects the implementation of the CCM.  Secondly, the 
participants had to have an official diabetes diagnosis in the electronic health record 
system.  
Data Collection Sources 
Patient registries. Data pertaining to A1C and LDL values was supplied by 
CCHCS, through the relevant diabetes patient registry. Patient registries are utilized by 
the care teams assigned to panels of patients to monitor relevant aspects of various 
chronic medical conditions. The registries utilize information that has been entered into 
the electronic health record system by the providers.  
Data warehouse. CCHCS maintains a data repository, known as the data 
warehouse. Here, all medical information is maintained and accessible for quality 
management and reporting purposes. For this study, the data warehouse was accessed to 
pull information related to transfers to a higher level of care. This information is 
maintained in the data warehouse. The Strategic Offender Management System is 
custody software that tracks all inmate movement, including when a patient is transferred 
internally to the outpatient housing unit, correctional treatment center, or to outside 
hospitals. In addition to this information, the electronic health record system contains 
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clinical documentation to indicate the reason for the referral to a higher level of care to 
ensure the transfer was associated with the patient’s diagnosis.  
Data Access 
A request for access to the data was submitted to the CDCR Office of Research, 
which maintains all requests and permissions for data pertaining to inmates and 
employees of the CDCR. The CDCR has a separate institutional review board (IRB) 
application process that requires written proof of educational association and institutional 
IRB approval. Once Walden University approved the study, the actual data request was 
processed and the requested information was then sent to the researcher, omitting all 
patient identifiers.  
Data Analysis 
Once the data was extracted from the sources discussed above, it will be sorted to 
separate data points for each of the hypotheses being analyzed. Each dependent variable 
was assessed using a repeated measures ANOVA to compare the pre- and post-CCM 
implementation values. A1C values were compared to determine if the CCM 
implementation had an effect on decreasing these values. The same analysis was 
completed for LDL values to determine whether the CCM implementation had a 
statistically significant impact on cholesterol levels for diabetic patients. Transfers to 
higher levels of care were also compared from pre- and post-CCM implementation. A 
power analysis was conducted to determine the sample size for this test. A total of 99 
participants were proposed through this analysis, with the power set at 0.80, α = 0.05, 
and testing for small to moderate effect sizes (Cohen, 1992).  
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Threats to Validity  
Mitigation of threats to the validity of the current study ensures that the 
intervention being studied had an impact on the dependent variables outlined above. 
There are several threats to validity to consider. For example, selection bias was assessed. 
In this study, selection of patients was contained to one CDCR institution, California 
Medical Facility, and all patients studied had been at the institution since at least 2014 to 
ensure they received treatment under the condition of the CCM, as well as prior to its 
implementation. Second, attrition of participants was mitigated by removing all patients 
who had paroled, transferred, or died prior to 2018, to ensure that the remaining 
participants were able to receive treatment both before and after the implementation of 
the CCM. History was the third threat to validity. Events within the prison system can be 
difficult to hold constant, and thus may pose some risk to validity. However, by selecting 
an institution with few lockdowns, due to its mission of housing lower-level offenders, 
meant that there was a less likely chance that treatment would have been interrupted due 
to problematic correctional concerns such as riots. Finally, the Hawthorne effect was not 
a concern in the current study, given the use of historical, secondary data. Because the 
participants did not know that their health outcome measures were being studied, there 
was no chance that the participants would alter behavior due to knowing that they were 
being studied.  
Ethical Considerations 
The data the CCHCS provided was secondary data that had all patient 
identification removed. As a result of the lack of patient information, there were no risks 
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for the disclosure of confidential or protected health information in this study. For ethical 
purposes, the Walden University IRB supervised the data analysis and study conclusions 
(IRB approval number 12-19-19-0758554). In addition, the CDCR Office of Research 
authorized the use of the inmate information and monitored the use of the data. The raw 
data was stored in a confidential manner, specifically without any patient-identifying 
indicators. All data will be retained for five years after the completion of this doctoral 
study and will then be destroyed.  
Summary 
This section described the secondary data that was used to conduct the 
quantitative analysis of archival data utilizing repeated measures ANOVAs. The purpose 
of this study was to determine the impact of the implementation of the CCM in the 
CDCR had on patient health outcomes for diabetic patients remanded to the custody of 
the CDCR. This section outlined the proposed methodology to be used to conduct this 
study and Section 3 will provide the statistical results relative to the research questions 
and hypotheses.  
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Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this study was to identify whether there would be a significant 
decrease in A1C and LDL values for diabetic patients after the implementation of a 
PCMH-type model within the CCHCS. In addition, I evaluated whether the number of 
referrals to specialty services, consisting of services that could not be provided within the 
prison setting and that were directly required for management of diabetes, would 
decrease after implementation of the PCMH model. The following research questions and 
hypotheses were proposed to address this purpose:  
Research Question 1: Will post-CCM implementation A1C values of diabetic 
patients in 2018 be significantly lower than 2014 A1C values? 
H01: For diabetic patients, the A1C levels will not be significantly lower after the 
implementation of the patient-centered medical home model.  
H11: For diabetic patients, the A1C levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
Research Question 2: Will post-CCM implementation LDL levels of diabetic 
patients in 2018 be significantly lower than 2014 LDL levels? 
H02: For diabetic patients, the LDL levels will not be significantly lower after the 
implementation of the patient-centered medical home model. 
H12: For diabetic patients, the LDL levels will be significantly lower after the 
implementation of the patient-centered medical home model.  
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Research Question 3: Is there a decrease in the number of referrals to higher 
levels of care, defined as outpatient housing unit, correctional treatment center, or 
community placement hospitalization, for diabetic patients from 2014 to 2018, 
representing the implementation of the patient-centered medical home model within 
CCHCS? 
H03: There is no significant change in the number of referrals to a higher level of 
care for diabetic patients after the implementation of the patient-centered medical home 
model.   
H13: There are fewer referrals to a higher level of care for diabetic patients after 
the implementation of the patient centered-medical home model.  
The remainder of this section will be comprised of a description of the data 
collection of the secondary data set, including recruitment and response rates, along with 
a detailed review of the statistical results organized by research question. Statistical 
assumptions for each of the analyses will also be discussed. The section will conclude 
with a summary. 
Data Collection of Secondary Data Set 
For the current study, archival data were used. Participants for this study consisted 
of males within the prison system who were assigned to the California Medical Facility 
(CMF). The time frame for the data points were from 2014 and 2018 to ensure data 
points were available prior to the CCM implementation and after it had been fully 
established. There was a total of 150 participants that met the screening criteria. For the 
current study, a power analysis showed that 99 participants were needed. After IRB 
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approval was obtained, access to the data occurred over several days. There were no 
discrepancies regarding the data set plan discussed in Section 2.  
A total of 150 participants were recruited for the analyses. While running the 
statistical assumptions, seven participants were removed due to the data points being 
outliers (additional details regarding the removal of these participants are provided in the 
following subsection). Therefore, a total of 143 participants were used for the analyses. 
Of the 143 participants, a total of 48.3% were African American (n = 69), 23.1% were 
Caucasian (n = 33), 19.6% were Hispanic (n = 28), 0.7% were American Indian (n = 1), 
and 8.3% were classified as Other (n = 12). The ages of the participants ranged from 30 
to 85 years old, with a median age of 63.00 and a mean age of 62.45 years old (standard 
deviation [SD] = 10.42). 
The population of interest for the current study was male prisoners diagnosed with 
diabetes. In 2011-2012, it was reported that within the United States, 899 per 100,000 
inmates were diagnosed with diabetes (Bureau of Justice Statistics, 2018). Research has 
also shown that this rate has doubled from 2014 (Diabetes Behind Bars, 2018). The 
ethnicity with the highest rates of diabetes in the prison population is among African 
American men (Nowotny, Rogers, & Boardman, 2017). Due to time restraints and the 
probable inability to obtain access to all of these individuals, one prison was focused on 
for the current study.   
Results 
Each of the three research questions were addressed by running a repeated 
measures ANOVA. First, the statistical assumptions of a repeated measures ANOVA 
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were assessed. After the statistical assumptions were addressed, descriptive statistics 
were run, followed by the primary analyses for each research question. In the following 
section, the statistical assumptions are reviewed first. Next, the descriptive statistics and 
primary analyses will be discussed and organized by research question. 
Statistical Assumptions 
There are three statistical assumptions for the repeated measures ANOVA. First, 
there should not be significant outliers in any level of the independent variable. Second, 
the dependent variable should have an approximate normal distribution for each level of 
the independent variable. Third, the assumption of sphericity needs to be met, which 
refers to equal variances of the differences between all combinations of levels of the 
independent variable (Warner, 2013). For each of the three repeated measures ANOVAs, 
these three statistical assumptions were assessed.  
To determine whether there were outliers, boxplots were computed and then 
examined. SPSS identifies outliers in a boxplot by highlighting the outliers that are 1.50 
and 3.00 box lengths away from the edge using a circle or asterisk, respectively (Warner, 
2013; see Figures 1, 2, and 3). 
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Figure 1. Boxplot for A1C levels for 2014 and 2018. 
 
Figure 2. Boxplot for LDL levels for 2014 and 2018. 
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Figure 3. Boxplot for referrals for 2014 and 2018. 
All of the highlighted outliers were considered for removal. To determine which 
outliers were removed, the researcher reviewed the participants’ specific values of the 
variables to determine whether to include or remove the outliers. Only extreme outliers 
were removed (Warner, 2013). From the interpretation of the A1C boxplot, one outlier 
was removed. For the LDL boxplot, four outliers were removed. For the care referral 
analysis, a total of two outliers were removed. Therefore, a total of seven outliers were 
removed before moving forward to testing the assumption of normality (N = 143).  
Normality was assessed using the Shapiro-Wilks test of normality for each 
repeated measures ANOVA. Normality was determined based on significance level, 
where values above .05 indicated that normality had been met (Warner, 2013). For the 
A1C, LDL, and referrals analyses, the assumption of normality was not met, as no 
significance values were above .05. However, since repeated measures ANOVAs are 
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robust to violations of normality (Warner 2013), the analysis was continued without data 
transformation. 
To test for the assumption of sphericity, no additional tests were needed, as 
sphericity values are automatically generated in SPSS when the repeated measures 
ANOVA is performed (Warner, 2013). Sphericity is assessed based on the significance 
value, where values above .05 indicate this assumption has been met (Warner, 2013). For 
each of the repeated measures ANOVA, sphericity was not met (p < .05). Therefore, the 
Greenhouse-Geisser values will be interpreted from the SPSS output to account for this 
violation (Warner, 2013). 
Research Question 1 
To address research question one, “Will post-CCM implementation A1C values 
of diabetic patients in 2018 be significantly lower than 2014 A1C values?”, a repeated 
measures ANOVA was performed. A repeated measures ANOVA was deemed most 
appropriate as ANOVAs provide a comparison between groups (Warner, 2013). In 
particular, a repeated measures ANOVA allows for a comparison of two or more 
observation points for the same group, often referred to as a within-subjects analysis 
(Warner, 2013). Using a repeated measures ANOVA allowed for a comparison of A1C 
levels before and after the implementation of the PCMH model. For this first analysis, the 
independent variable was time (before and after the intervention), while the dependent 
variable was A1C levels. Prior to running the repeated measures ANOVA, descriptive 
statistics for the A1C levels were performed. Table 1 presents the mean, SD, and range 
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for both the pre- and post-A1C scores. The mean A1C pre-scores were M = 7.43 (SD = 
1.62), while the mean A1C post-scores were M = 7.19 (SD = 1.37). 
Table 1 
 
Descriptive Statistics for the Pre- and Post-A1C Scores 
Variable Range Mean SD 
2014 A1C 5.15-11.53 7.43 1.62 
2018 A1C 5.05-11.44 7.19 1.37 
 
The results of the repeated measures ANOVA showed that there was a 
statistically significant decrease in A1C values from 2014 (M = 7.43, SD = 1.62) to 2018 
(M = 7.19, SD = 1.37), F(1.00, 142.00) =4.68, p = .032 (see Table 2). The mean 
difference was 0.24 with a 95% confidence interval ranging from 0.09 to 0.52. The effect 
size was determined by calculating the eta squared value (eta squared = .032) and this 
value indicates a small effect size (.06 is considered a moderate effect size; Warner, 
2013). For research question one, the null hypothesis was rejected (p = .032). These 
results indicate that A1C levels were significantly lower after the implementation of the 
PCMH model. 
Table 2 
 
Results for the Repeated Measures ANOVA for A1C Levels 
Variables F-value 
Mean 
Difference 
95% Confidence 
Intervals 
Effect 
Size Sig. Value 
A1C Levels 4.68 0.24 0.021 to 0.469 0.032 .032* 
Note. Sig. = Significance; p < .05* 
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Research Question 2 
For research question two, “Will post-CCM implementation LDL levels of 
diabetic patients in 2018 be significantly lower than 2014 LDL levels?”, another repeated 
measures ANOVA was performed. For this analysis, the independent variable was time 
(before and after the intervention), while the dependent variable was LDL values. Prior to 
running the repeated measures ANOVA, descriptive statistics for the pre- and post-LDL 
levels were performed (see Table 3). For the LDL scores, the pre-score mean was M = 
77.99 (SD = 25.34) and the post-score mean was M = 77.87 (SD = 26.54).  
Table 3 
 
Descriptive Statistics for the Pre- and Post-LDL Scores 
Variable Range Mean SD 
2014 LDL 30.00-147.50 77.99 25.34 
2018 LDL 29.50-154.00 77.87 26.54 
 
The results of the repeated measures ANOVA showed that there was not a 
statistically significant decrease in LDL values from 2014 (M = 77.99, SD = 25.34) to 
2018 (M = 77.87, SD = 26.54), F(1.00, 142.00) = 0.003, p = .959 (see Table 4). The mean 
difference was 0.12 with a 95% confidence interval ranging from -4.30 to 4.53. The 
effect size was determined by calculating the eta squared value (eta squared = .00) and 
this value indicates a small effect size (Warner, 2013). For research question two, the null 
hypothesis was accepted (p = .959). These results indicate that the LDL levels were not 
significantly lower after the implementation of the PCMH model. 
45 
 
Table 4 
 
Results for the Repeated Measures ANOVA for LDL Levels  
Variables t-value 
Mean 
Difference 
95% Confidence 
Intervals 
Effect 
Size Sig. Value 
LDL Levels .003 0.12 -4.30 to -4.53 0.00 0.959 
Note. Sig. = Significance; p < .05* 
Research Question 3 
For research question three, “Is there a decrease in the number of referrals to 
higher levels of care, defined as Outpatient Housing Unit, Correctional Treatment Center, 
or community placement hospitalization, for diabetic patients from 2014 to 2018, 
representing the implementation of the Patient Centered Medical Home model within 
CCHCS?”, another repeated measures ANOVA was performed. For this analysis, the 
independent variable was time (before and after the intervention), while the dependent 
variable was the number of referrals. 
Prior to running the repeated measures ANOVA, descriptive statistics for the pre- 
and post-referral scores were performed. Table 5 presents the mean, SD, and range for the 
pre- and post-referral scores. The referral pre-score was M = 0.40 (SD = 1.06), while the 
post-score was M = 0.80 (SD = 1.65). 
Table 5 
 
Descriptive Statistics for the Pre- and Post-Referral Scores 
Variable Range Mean SD 
2014 Referral 0.00-7.00 0.40 1.06 
2018 Referral 0.00-8.00 0.80 1.65 
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The results of the repeated measures ANOVA showed that there was a 
statistically significant increase in referrals from 2014 (M = 0.40, SD = 1,06) to 2018 (M 
= 0.80, SD = 1.65), F(1.00, 142.00) = 8.14, p = .005 (see Table 6). The mean difference 
was -0.40 with a 95% confidence interval ranging from -0.687 to -.125. The effect size 
was determined by calculating the eta squared value (eta squared = .054) and this value 
indicates a small, bordering on moderate effect size (Warner, 2013). For research 
question three, the null hypothesis was rejected (p = .005). However, the results were in 
the opposite direction than predicted. In particular, these results indicated that there were 
significantly more referrals to higher levels of care (i.e., the Outpatient Housing Unit, the 
Correctional Treatment Center, or community placement hospitalization) after the 
implementation of the PCMH model.  
Table 6 
 
Results for the Repeated Measures ANOVA for Pre- and Post-Referral Scores 
Variables t-value 
Mean 
Difference 
95% Confidence 
Intervals 
Effect 
Size Sig. Value 
Referrals 8.14 -0.40 -0.687 to -0.125 0.054 .005* 
Note. Sig. = Significance; p < .05* 
Summary 
Three overarching research questions were proposed and addressed in the current 
study. For research question one, the alternative hypothesis was accepted (p = .032), and 
the results showed that A1C levels were significantly lower after the implementation of 
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the PCMH model. For research question two, the alternative hypothesis was rejected (p = 
.959). The results of research question two suggest that LDL levels did not significantly 
decrease after the implementation of the PCMH model. Finally, for research question 
three, the alternative hypothesis was accepted (p = .005), suggesting that there were 
significantly more referrals to higher levels of care (i.e., the Outpatient Housing Unit, the 
Correctional Treatment Center, or community placement hospitalization) after the 
implementation of the PCMH model, which could be due to increased oversight of 
patients due to implementation of the CCM.  When a care team is able to more closely 
monitor a patient, concerning health indicators can be identified quickly and decisions to 
place in an inpatient setting can be made to reduce the negative impacts on the patient. 
However, although the null hypothesis was rejected, the results of research question three 
were in the opposite direction that was initially predicted, as the researcher predicted 
referrals would decrease after implementation of the PCMH model, and they increased. 
To summarize, although A1C levels were significantly lower after the intervention, LDL 
levels did not differ, and the number of referrals to higher levels of care were 
significantly higher after the intervention. 
Section three provided a detailed account of the statistical results used to address 
the three research questions. In Section 4 of the dissertation, an interpretation of these 
findings will be presented. Specifically, whether the findings confirmed or disconfirmed 
the previous literature and relevant theories will be discussed. How these findings extend 
the current knowledge in this discipline will also be highlighted, along with a discussion 
of the limitations of the current study and future research recommendations. Implications 
48 
 
for how the results of this study could impact positive social change will also be 
discussed. 
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Section 4: Application to Professional Practice and Implications for Social Change   
Introduction 
The objective of this study was to determine whether there was a 
relationship between the LDL and A1C values of diabetic patients and the 
implementation of the PCMH model within the CCHCS through secondary quantitative 
data. Additionally, I analyzed the relationship between the CCM implementation and the 
numbers of referrals to specialty services, consisting of services that cannot be provided 
within the prison setting and that are directly required for management of diabetes. Early 
identification of the need for specialty care can positively improve health outcomes for 
these patients, and the CCM of treatment delivery advocates for collaboration of care for 
patients. A demonstration of these relationships will exemplify the strengths of the CCM 
in CCHCS within a controlled and institutionalized environment for chronic medical 
conditions such as diabetes. 
Further, administrators can use the PCMH model for coordination of care of the 
chronically medically ill patients. However, without empirical research showing that 
within a prison setting the PCMH model can reduce the impacts of chronic illnesses, 
there is no validated evidence to support its use. Additionally, typical managed care 
models of healthcare involve litigation problems, despite some departments of correction 
attempting to employ them (Sonntag, 2017). 
Interpretation of the Findings 
The findings show that after the implementation of the CCM, A1C values, on 
average, were lower among the patients sampled. Although LDL values were not 
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statistically lower after the implementation of the CCM, the data trended in the correct 
direction. When reviewing referrals to a high level of care from 2014-2018, there was a 
significant increase in referrals over the timeframe, which is opposite of what was 
anticipated. Initially, it was expected that the CCM would reduce referrals to specialty 
services as a result of the creation of electronic registries that can assist care teams in 
identifying patients who are out of range for specific diabetic markers. The increase in 
referrals might demonstrate that the CCM is functioning as intended by maintaining 
increased oversight of the assigned patient panels to care teams, who are able to 
recognize patients that require expedited referrals to treatment regimens not readily 
available within the correctional setting.  
Limitations of the Study 
Although the results of the study were positive, there are limitations regarding the 
generalizability of the findings. First, the sample was pulled from a single institution 
within the CDCR—the California Medical Facility, which houses inmates who have 
significant medical and mental health concerns. The California Medical Facility inmate 
population may present confounding variables that make the management of diabetes 
difficult. Such confounds include comorbid medical and mental health issues and a large 
number of inmates being on medications that may have side effects that impact diabetes 
management.   
A second limitation to the findings of this study was that the implementation of 
the CCM continues to be in its infancy. Although the CCM has been in place for nearly 4 
years, the size of the enterprise of the CCHCS makes adoption of large initiatives such as 
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the CCM an extended process. As the CCM evolved, more resources and tools have 
become available and continue to be in production to assist care teams. Thus, it may have 
been beneficial to look at the change in A1C and LDL values at the start of 
implementation of the CCM and then again at intervals, as the CCM has been evolving 
and improving.   
Due to the permissions given by CDCR, the sample size was 143 participants.  
After conducting the power analysis, this sample is identified as being small to medium.  
Had more CDCR institutions been included in the study, the power of the sample size 
would have been larger. However, introducing other institutions into the study would 
have also introduced more confounds that would have had to be accounted for in the 
statistics.  The use of participants only at the California Medical Facility reduced the 
likelihood that patients would have transferred to other prison facilities, which would 
have incorporated an additional confound that would need to be studied 
Recommendations 
Further research is needed to understand the practicality and efficacy of the CCM 
within correctional settings. There are myriad other chronic illnesses that will require the 
same level of analysis to determine if the CCM is an effective treatment modality. In 
addition, to understand how the CCM can improve chronic illness, it is important to 
consider the long-term impact of the CCM on maintaining improved healthcare indicators 
in correctional settings. As such, it is recommended that longitudinal studies should be 
utilized to see how effective the CCM is over time. In addition, with an aging population, 
understanding the long-term benefits of a treatment modality is critical.   
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As noted in the limitations, this study was conducted with a sample of patients 
housed in a medical facility within the CDCR. Thus, there was a larger proportion of 
patients with chronic illness housed in that institution, which could skew outcome 
measures. This sample was also only a small minority of the overall population in 
California prisons. Conducting this type of research on less chronically ill patients at 
other institutions within the CDCR could help assess the reliability of the CCM across the 
prison population.  
Implications for Professional Practice and Social Change 
Professional Practice 
This study suggests that the CCM is a valuable treatment modality to consider 
within institutionalized settings. Given the limitations of medical practice in prison, the 
fact that the CCM is able to demonstrate some success for chronic illness, such as 
diabetes, suggests that this model could be used effectively. Although the structure of 
prison can have limitations, the physical layout and structure of many prisons allows for 
an implementation of a treatment delivery model like the CCM for patient paneling, in 
particular. However, and more importantly, the implementation of the CCM would allow 
the care teams to be close to the living environment of the patients which can help the 
care team members better understand the way of life of the patients. Education is also 
more readily accessible by patients, as well, given their close proximity to care providers. 
For correctional entities struggling to manage chronic illnesses, such as diabetes, the 
CCM may be important to consider to help stabilize these patients.  
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The social construct theory in healthcare focuses on the relationships developed 
between provider and patient (Hirshfield & Underman, 2017). The CCM helps foster this 
theory through the creation of care teams that are dedicated to treating specific patient 
who are grouped into panels to which providers are assigned. These care teams follow 
patients for extended periods of time, which helps the care team learn about the unique 
needs of the individual patients on their panel. By creating a framework for routinely 
working collaboratively as a team, the CCM in prison settings fosters an environment of 
humanizing inmates and attending to the medical needs in a humane and ethical manner.  
The more correctional agencies that consider implementing the CCM, the better providers 
are able to care for more inmates across the country that inevitably reenter society.  
Positive Social Change 
Although there is a subset of individuals incarcerated in California prisons, many 
more have release dates. Because of this fact, it is important to develop a treatment 
modality for individuals while incarcerated that can effectively treat and manage medical 
conditions and prepare these inmates for a healthy life in the community. A key 
component of the CCM is education (Janiszewski et. al., 2015). By providing effective 
treatment coupled with education on healthy lifestyle choices, paroling inmates can gain 
control of their health and make appropriate choices based on a foundational education 
provided by the medical staff within the prison setting.   
Additionally, a healthy inmate population is indicative of a culture that promotes 
health to all facets of the population. Although inmates have committed crimes, they are 
making amends to the community through their incarceration. Unnecessary suffering 
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while making those amends is unconstitutional and demonstrative of cruel and unusual 
punishment. Conversely, ensuring constitutionally adequate healthcare for all inmates 
represents a commitment to ethical and humane behavior.  
Using the CCM, and educating the patients on their health condition and the best 
way to maintain a quality of life, inmates are able to release to society healthier than 
when they arrived with a renewed sense of purpose and self-determination to make other 
positive changes in their lives. Healthy individuals are able to focus attention on 
attending to treatment and rehabilitative programs that can assist in making the changes 
necessary to lead successful lives when they are returned to the community.   
Conclusion 
In conclusion, the results of this study show a positive change in the delivery of 
medical treatment for some of the most disenfranchised individuals of society.  
Incarcerated individuals deserve an opportunity to receive constitutionally adequate 
medical care while serving sentences for crimes they committed. Historically, inmates 
were not provided the opportunity to receive treatment for chronic illness (Sonntag, 
2017). This proved to perpetuate a financial burden into the community, as prisoners 
were released with uncontrolled illnesses and would then seek treatment in emergency 
departments in the community because most lacked medical insurance Sonntag, 2017). 
Although it may be controversial to spend large amounts of money on inmates, the 
positive changes seen in the health of individuals who are ostensibly being rehabilitated 
for reentry into society are priceless.    
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When left untreated, inmates are forced to needlessly suffer from chronic illnesses 
that are readily managed by individuals in the community. This suffering leads to 
increased costs to the correctional systems as well as the community at large because 
funds must be reallocated from other agencies to support skyrocketing costs of 
inadequate and ineffective medical treatment (Kelso, 2015). By continuing to enhance the 
treatment delivery to inmates, inmates are able to focus their attention on positive 
programming behind the prison walls to prepare themselves for successful reentry into 
the community.   
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